Affinity and selectivity of PD156707, a novel nonpeptide: Endothelin antagonist, for human ET(A) and ET(B) receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 1102-1108

  Maguire, Janet J ^a   Kuc, Rhoda E ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE];

ADULT; AGED; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CORONARY ARTERY; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; ISCHEMIA; KIDNEY; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SAPHENOUS VEIN; VASOSPASM;

ADULT; AGED; AGED, 80 AND OVER; BINDING, COMPETITIVE; CORONARY VESSELS; DIOXOLES; ENDOTHELIN-1; FEMALE; HEART; HEART VENTRICLES; HUMANS; KIDNEY; KINETICS; MALE; MAMMARY ARTERIES; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SAPHENOUS VEIN;

EID: 0030985630     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ARAI, H., HORI, S., ARAMORI, I., OHKUBO, H. AND NAKANISHI, S.: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732, 1990.
2. AHUNLAKSHANA, O. AND SCHILD, H. O.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14: 48-58, 1959.
3. CHESTER, A. H., O'NEIL, G. S., ALLEN, S. P., LUU, T. N., TADJKARIMAI, S. AND YACOUB, M. H.: Effect of endothelin on normal and diseased human coronary arteries. Eur. J. Clin. Invest. 22: 210-213, 1992.
4. CLARKE, J. G., BENJAMIN, N., LARKIN, S. W., WEDB, D. J., DAVIES, G. J. AND MASERI, A.: Endothelin is a potent long-lasting vasoconstrictor in men. Am. J. Physiol. 257: H2033-H2035, 1989.
5. A receptor antagonist prevents the early vasospasm following suharachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci. 52: 825-834, 1993.
6. A receptors in human kidney which localizes to renal vasculature. Br. J. Pharmacol. 113: 1303-1310, 1994.
7. 125I]endothelin1 in humans, pigs and rats: Functional relevance in humans. J. Cardiovasc. Pharmacol. 13: suppl. 5, S166-S170, 1989.
8. A sub-type. Br. J. Pharmacol. 114: 1110-1116, 1995.
9. A) receptor-selective antagonists. J. Med. Chem. 38: 1259-1263, 1995.
10. GODFRAIND, T.: Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol. 110: 1201-1205, 1993.
11. HAY, D. W. P., LUTTMANN, M. A., HUBBARD, W. C. AND UNDEM, B. J.: Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br. J. Pharmacol. 110:1175-1183, 1993.
12. HAYNES, G. H., FERRO, C. E. AND WEBB, D. J.: Physiologic- role of endothelin in maintenance of vascular tone in humans. J. Cardiovasc. Pharmacol. 26: suppl. 3, S183-S185, 1995.
13. HUGGINS, J. P., PELTON, J. T. AND MILLER, R. C.: The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol. Ther. 59: 55-123, 1993.
14. IDE, K., YAMAKAWA, R., NAKAGOMI, T., SASAKI, T., SAITO, I., KURIHARA, H., YosiZUMI, M., YAZAKI, Y. AND TAKAKURA, K.: The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol. Res. 11: 101-104, 1989,
15. b in human kidney. Ridney Int. 44: 36-42, 1993.
16. MCPHERSON, G. A.: A practical computer based approach to the analysis of radioligand binding experiments. Comput. Methods Program Biomed. 17: 107-114, 1983.
17. A receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br. J. Pharmacol. 115: 191-197, 1995.
18. A receptor antagonist, for human endothelin receptors. J. Cardiovasc, Pharmacol. 26: suppl. 3, S362-S364, 1995.
19. A selective non-peptide antagonist PD156707 for endothelin receptors in human renal and cardiovascular tissues. Br, J. Pharmacol. 117: 35P, 1996.
20. MAGUIRE, J. J., KUC, R. E., O'REILLY, G. AND DAVENPORT, A. P.: Vasoconstrictor endothelin receptors characterised in human renal artery and vein in vitro. Br. J. Pharmacol. 113: 49-54, 1994.
21. MASAKI, T., KIMURA, S., YANAGISAWA, M. AND GOTO, K.: Molecular and cellular mechanisms of endothelin regulation. Circulation 85: 1457-1468, 1991,
22. MASAOKA, H., SUZUKI, R., HIRATA, Y., EMORI, T., MARUMO, F. AND HIRAKAWA, K.: Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet 2: 1402, 1989.
23. 1,3,11,15]]ET-l in human heart. Br. J. Pharmacol. 107: 637-639, 1992.
24. MUNSON, P. J. AND RODBARD, D.: LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107: 220-239, 1980.
25. OPGAARD, O. S., ADNER, M., GULBENKIAN, S. AND EDVINSREN, L.: Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J. Cardiovasc. Pharmacol. 23: 576-583, 1994,
26. PATEL, T. R., GALBRAITH, S., GRAHAM, D. I., HALLAK, H., DOHERTY, A. M. AND MCCULLOCH, J.: Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J. Cereb. Blood Flow Metab. 16: 950-958, 1996.
27. REYNOLDS, E. E., HWANG, O., FLYNN, M. A., WELCH, K. M., CODY, W. L., STEINBAUGH, B., HE, J. X., CHUNG, F-Z. AND DOHERTY, A. M.: Pharmacological differences between rat and human endothelin B receptors. Biochein. Biophys. Res. Commun. 200: 506-512, 1995a.
28. A receptor antagonist. J. Pharmacol. Exp. Ther. 273: 1410-1417, 1995b.
29. RIEZEBOS, J., WATTS, I. S. AND VALLANCE, J. T.: Endothelin receptors mediating functional responses in human small arteries and veins. Br. J. Pharmacol. 111: 609-615, 1994.
30. B selective compounds in human and rat heart. Br. J. Pharmacol. 117: 36P, 1996.
31. SAKURAI, T., YANAGIHAWA, M., TAKUWA, Y., MIYAZAKI, H., KIMURA, S., GOTO, K. AND MASAKI, T.: Clonong of a cDNA encoding a non-isopeptide-selective subtype of endothelin receptor. Nature 348: 732-735, 1990.
32. WEITZBERG, E., AHLBORG, G. AND LUNDBERG, J. M.: Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem. Biophys. Res. Commun. 180:1298-1303, 1991.
33. YANAGISAWA, M., KUWKARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. AND MASAKI, T.: A novel potent vasoconstriction peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
34. YANG, Z., RICHARD, V., VON SEGESSER L., BAUER, E., STULZ, P., TUKINA, M. AND LUSCHER, T. F.: Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 82:188-195, 1990.